One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-128857
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
Affiliation: Curis (United States), Memorial Sloan Kettering Cancer Center, Emory University, USC Norris Cancer Hospital, University of Southern California, University of Michigan–Ann Arbor, University of California, Los Angeles, University of Pennsylvania, University of Chicago, Fox Chase Cancer Center, Swedish Medical CenterA Multi-Center Dose-Finding Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Fimepinostat (CUDC-907) in Combination with Venetoclax in Patients with Relapsed/Refractory (R/R) Lymphoma
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
